🇺🇸 FDA
Patent

US 11478428

Combinations of beta-lactam compounds and probenecid and uses thereof

granted A61KA61K31/195A61K31/397

Quick answer

US patent 11478428 (Combinations of beta-lactam compounds and probenecid and uses thereof) held by Iterum Therapeutics International Limited expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Iterum Therapeutics International Limited
Grant date
Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/195, A61K31/397, A61K31/431, A61K9/2013